Tokyo (JCN) Oct 13, 2005- Alfresa Holdings and Novartis Pharma jointly announced on October 11 that they have agreed on the production and distribution of Anafranil, Novartis Pharma’s proprietary antidepressant agent.
Tokyo (JCN) Oct 13, 2005- Alfresa Holdings and Novartis Pharma jointly announced on October 11 that they have agreed on the production and distribution of Anafranil, Novartis Pharma’s proprietary antidepressant agent.